Detalhe da pesquisa
1.
Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL.
Blood
; 136(25): 2918-2926, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603412
2.
A limited number of double-strand DNA breaks is sufficient to delay cell cycle progression.
Nucleic Acids Res
; 46(19): 10132-10144, 2018 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30184135
3.
Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation.
Leukemia
; 37(6): 1268-1276, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37100883
4.
Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia.
Cancers (Basel)
; 13(12)2021 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34205588
5.
Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers.
Front Immunol
; 10: 2215, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31611871
6.
Three-dimensional histochemistry and imaging of human gingiva.
Sci Rep
; 8(1): 1647, 2018 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29374186